Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Joaquim Bellmunt
Based on 63 articles published since 2007
||||
Expertise Level
The expertise of Joaquim Bellmunt ranks in the Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 29198325
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada. · Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · PSMAR-IMIM Lab, Bladder Cancer Center, Department of Medicine, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA. · Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Bioinformatics and Systems Biology Laboratory, Federal University of Paraná Polytechnic Center, Curitiba, PR CEP 80.060-000, Brazil. · Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Biostatistics and Computational Biology Laboratory, Department of Statistics, University of Campinas, São Paulo, 13.083-859, Brazil. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Biospecimen Core Resource, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pathology and Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD 21218, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. Electronic address: · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: · Pubmed 28988769
  • University of Texas MD Anderson Cancer Center, 1515 Pressler Unit 1373, Houston, TX, 77030, USA. · Dana-Farber Cancer Institute, Brookline, MA, 02446, USA. · Tisch Cancer Institute at Mount Sinai Medical Center, New York, NY, 10029, USA. · University of Minnesota, Minneapolis, MN, 55455, USA. · BCG Oncology, Phoenix, AZ, 85032, USA. · Bladder Cancer Advocacy Network, North Carolina Triangle Chapter, Chapel Hill, NC, 27517, USA. · The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. · University of North Carolina, Chapel Hill, NC, 27599, USA. · University of Iowa, Iowa City, IA, 52242, USA. · University of Chicago, Chicago, IL, 60637, USA. · Yale Cancer Center, New Haven, CT, 06520, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Stanford University, Stanford, CA, 94305, USA. · University of Alabama, Birmingham, AL, 35294, USA. · University of Kansas Cancer Center, Kansas City, KS, 66160, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Pubmed 28807024
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Pitié-Salpêtriére Hospital, Pierre and Marie Curie University, Paris, France. · Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28743155
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28412065
2016
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts3Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27310333
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
  • Thomas Seisen, Maxine Sun, Jeffrey J. Leow, Mark A. Preston, Alexander P. Cole, Francisco Gelpi-Hammerschmidt, Nawar Hanna, Christian P. Meyer, Adam S. Kibel, Stuart R. Lipsitz, Paul L. Nguyen, and Quoc-Dien Trinh, Brigham and Women's Hospital; and Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27269944
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Pathology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Precision Oncology Laboratory, Infanta Sofia University Hospital, Madrid, Spain. · Department of Surgery, Jimenez Diaz Foundation, Madrid, Spain. · Clinical Research Unit, Jimenez Diaz Foundation, Madrid, Spain. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, USA. · Pubmed 27111282
  • University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, AL, USA. Electronic address: · McMaster University, Ontario, Canada. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 26415779
  • University of Alabama-Birmingham Comprehensive Cancer Center, Birmingham, Alabama. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Pubmed 26292040
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 27806880
2015
  • Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Electronic address: · Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25935702
  • Director, Bladder Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, 450 Brookline Ave., Boston, MA 02215, USA. Electronic address: · Pubmed 25836942
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, 45, Francis street, Boston, MA 02115, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 26612221
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Ave. S., Birmingham, AL 35294, USA. · Bladder Cancer Institute, Dana Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Boston, 450, Brookline Ave, MA 02215, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Padiglioni Flajani, 1st Floor, Circonvallazione Gianicolense 87, Rome 00152, Italy. Electronic address: · Pubmed 25836940
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · VUI Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26320810
  • Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California. · Department of Urology, Guy's and St. Thomas' Hospital, London, United Kingdom. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Southampton General Hospital, Southampton, United Kingdom. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Division of Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Medical Oncology, Barts Cancer Institute, London, United Kingdom. · Division of Biostatistics, Department of Preventative Medicine, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology, Georges François Leclerc Center, Dijon, France. · Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · Department of Hematology and Oncology, Barbara Ann Karmanos Cancer Center, Detroit, Michigan. · Department of Medical Oncology, Samuel and Barbara Sternberg Cancer Research Foundation, Rome, Italy. · Department of Medical Oncology, University Hospital of Lausanne, Lausanne, Switzerland. · Department of Medical Oncology, Foundation IRCCS National Cancer Institute, Milan, Italy. · Department of Oncology, Hospital Foch, Suresnes, France. · Division of Hematology and Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25872978
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
  • Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Statistics, McMaster University, Hamilton, Ontario, Canada. · Department of Medicine, University Federico II, Naples, Italy. · Department of Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medicine, City of Hope Cancer Center, Duarte, CA. · Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT. · Department of Medicine, Wayne State University Cancer Center, Detroit, MI. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medicine, University of Arizona, Tucson, AZ. · Department of Medicine, Dana Farber Cancer Institute, Boston, MA. · Department of Medicine, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 25450035
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Barts Cancer Institute, Queen Mary University of London, Barts Experimental Cancer Medicine Centre, London EC1M 6BQ, UK. · Yale Cancer Center, 333 Cedar Street, WWW211, New Haven, Connecticut 06520, USA. · Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, USA. · Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Gustave Roussy, 114 Rue Édouard Vaillant, 94805 Villejuif, France. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital. Passeig Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · Sarah Cannon Research Institute, 3322 West End Avenue, Suite 900, Nashville, Tennessee 37203, USA. · University of Nevada School of Medicine and US Oncology/Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Pubmed 25428503
  • Division of Urology and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24568895
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Department of Urology, Stanford University Medical Center, Stanford, CA, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24491306
  • Fox Chase Cancer Center, Philadelphia, PA · Thomas Jefferson University Hospital, Philadelphia, PA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Fox Chase Cancer Center, Philadelphia, PA. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25385730
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
2015
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 24674655
2014
  • Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Christopher Tretter, Lahey Clinic, Burlington; Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA; Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA; and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Christopher Tretter, Lahey Clinic, Burlington; Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA; Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA; and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24821883
  • Dana-Farber Cancer Institute, Boston, Massachusetts; University of Rochester, Rochester, New York. · Pubmed 24846059
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2012
  • Department of Imaging, Dana-Farber Cancer Institute, MA, USA. · Pubmed 22176867
Probable:    Hospital del Mar      
2017
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • University of Washington, Seattle, Washington. · Icahn School of Medicine at Mount Sinai, New York, New York. · University of Southampton, Southampton, England. · National and Kapodistrian University of Athens, Athens, Greece. · Dana Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Hospital del Mar, Barcelona, Spain. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Georges François Leclerc Center, Dijon, France. · Université de Bourgogne, Dijon, France. · Barts and the London School of Medicine, London, England. · City of Hope, Duarte, California. · Heinrich-Heine-University, Düsseldorf, Germany. · University of Michigan, Ann Arbor, Michigan. · University of Utah, Salt Lake City, Utah. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Karmanos Cancer Institute, Detroit, Michigan. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28000388
2016
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
2015
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • UAB Comprehensive Cancer Center, Birmingham, AL. · University Hospital del Mar-IMIM, Barcelona, Spain. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Heinrich Heine University, Dusseldorf, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Institut de Recherche Pierre Fabre, Boulogne, France. · Fox Chase Cancer Center, Philadelphia, PA. · Princess Margaret Hospital, Toronto, ON, Canada. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of North Carolina, Chapel Hill, NC. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · McMaster University, Hamilton, ON, Canada. · Pubmed 25035282
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Department of Internal Medicine/Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · University Hospital del Mar-IMIM, Barcelona, Spain. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Department of Medicine/Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Institut de Recherche Pierre Fabre, Boulogne, France. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Department of Medicine, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medicine/Hematology and Medical Oncology, Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · Department of Internal Medicine/Medical Oncology, Yale University Cancer Center, New Haven, CT. · Department of Oncology, Wayne State University, Detroit, MI. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. · Department of Medicine/Hematology-Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medicine/Hematology-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 24220220
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
2011
2010
  • Department of Medical Oncology, University Hospital Del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain. · Pubmed 20231682
2008
  • Department of Medical Oncology, University Hospital del Mar, Barcelona, Spain. · Pubmed 18707804
  • Medical Oncology Service, University Hospital Del Mar, Paseo Maritimo 25-29, Barcelona, Spain. · Pubmed 18538178
2007
  • Hospital del MAR-IMAS, Autónoma University of Barcelona, Barcelona, Spain. · Pubmed 17382797
2015
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
2014
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2011
  • Medical Oncology Service, University Hospital del Mar, Barcelona, Spain. · Pubmed 21360040
Probable:    Miscellaneous institutions in Barcelona      
2015
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 63 total) written by Joaquim Bellmunt about Urinary Bladder Neoplasms:

  • ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis. 2017
  • The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review. 2017
  • Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives. 2017
  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. 2017
  • Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. 2017
  • Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. 2017
  • Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. 2017
  • Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival. 2017
  • Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy. 2016
  • Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma. 2016
Show List of Full Article Records
Google Searches

Learn more about Joaquim Bellmunt using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
Hospital del Mar
Miscellaneous institutions in Barcelona
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2017
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 29198325
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada. · Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · PSMAR-IMIM Lab, Bladder Cancer Center, Department of Medicine, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA. · Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Bioinformatics and Systems Biology Laboratory, Federal University of Paraná Polytechnic Center, Curitiba, PR CEP 80.060-000, Brazil. · Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Biostatistics and Computational Biology Laboratory, Department of Statistics, University of Campinas, São Paulo, 13.083-859, Brazil. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA. · Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Biospecimen Core Resource, The Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pathology and Medical Oncology, Dana-Farber Cancer Institute and Harvard University, Boston, MA 02115, USA. · Greenberg Bladder Cancer Institute, Johns Hopkins University, Baltimore, MD 21218, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. Electronic address: · Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: · Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: · Pubmed 28988769
  • University of Texas MD Anderson Cancer Center, 1515 Pressler Unit 1373, Houston, TX, 77030, USA. · Dana-Farber Cancer Institute, Brookline, MA, 02446, USA. · Tisch Cancer Institute at Mount Sinai Medical Center, New York, NY, 10029, USA. · University of Minnesota, Minneapolis, MN, 55455, USA. · BCG Oncology, Phoenix, AZ, 85032, USA. · Bladder Cancer Advocacy Network, North Carolina Triangle Chapter, Chapel Hill, NC, 27517, USA. · The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. · University of North Carolina, Chapel Hill, NC, 27599, USA. · University of Iowa, Iowa City, IA, 52242, USA. · University of Chicago, Chicago, IL, 60637, USA. · Yale Cancer Center, New Haven, CT, 06520, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Stanford University, Stanford, CA, 94305, USA. · University of Alabama, Birmingham, AL, 35294, USA. · University of Kansas Cancer Center, Kansas City, KS, 66160, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. · Pubmed 28807024
  • Division of Urological Surgery, Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Pitié-Salpêtriére Hospital, Pierre and Marie Curie University, Paris, France. · Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 28743155
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 28412065
2016
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts3Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27310333
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
  • Thomas Seisen, Maxine Sun, Jeffrey J. Leow, Mark A. Preston, Alexander P. Cole, Francisco Gelpi-Hammerschmidt, Nawar Hanna, Christian P. Meyer, Adam S. Kibel, Stuart R. Lipsitz, Paul L. Nguyen, and Quoc-Dien Trinh, Brigham and Women's Hospital; and Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27269944
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Pathology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. · Precision Oncology Laboratory, Infanta Sofia University Hospital, Madrid, Spain. · Department of Surgery, Jimenez Diaz Foundation, Madrid, Spain. · Clinical Research Unit, Jimenez Diaz Foundation, Madrid, Spain. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, USA. · Pubmed 27111282
  • University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, AL, USA. Electronic address: · McMaster University, Ontario, Canada. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 26415779
  • University of Alabama-Birmingham Comprehensive Cancer Center, Birmingham, Alabama. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Pubmed 26292040
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 27806880
2015
  • Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Electronic address: · Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25935702
  • Director, Bladder Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Associate Professor, Harvard Medical School, 450 Brookline Ave., Boston, MA 02215, USA. Electronic address: · Pubmed 25836942
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, 45, Francis street, Boston, MA 02115, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 1230 DANA, 450 Brookline Ave, Boston, MA 02215, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 26612221
  • University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, 1720 2nd Ave. S., Birmingham, AL 35294, USA. · Bladder Cancer Institute, Dana Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, Boston, 450, Brookline Ave, MA 02215, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Padiglioni Flajani, 1st Floor, Circonvallazione Gianicolense 87, Rome 00152, Italy. Electronic address: · Pubmed 25836940
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · VUI Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, MI. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26320810
  • Department of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California. · Department of Urology, Guy's and St. Thomas' Hospital, London, United Kingdom. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Southampton General Hospital, Southampton, United Kingdom. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Division of Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Department of Medical Oncology, Barts Cancer Institute, London, United Kingdom. · Division of Biostatistics, Department of Preventative Medicine, Mount Sinai Medical Center, New York, New York. · Department of Medical Oncology, Georges François Leclerc Center, Dijon, France. · Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · Department of Hematology and Oncology, Barbara Ann Karmanos Cancer Center, Detroit, Michigan. · Department of Medical Oncology, Samuel and Barbara Sternberg Cancer Research Foundation, Rome, Italy. · Department of Medical Oncology, University Hospital of Lausanne, Lausanne, Switzerland. · Department of Medical Oncology, Foundation IRCCS National Cancer Institute, Milan, Italy. · Department of Oncology, Hospital Foch, Suresnes, France. · Division of Hematology and Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Division of Genitourinary Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25872978
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
  • Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Statistics, McMaster University, Hamilton, Ontario, Canada. · Department of Medicine, University Federico II, Naples, Italy. · Department of Medicine, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medicine, City of Hope Cancer Center, Duarte, CA. · Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT. · Department of Medicine, Wayne State University Cancer Center, Detroit, MI. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medicine, University of Liverpool, Liverpool, United Kingdom. · Department of Medicine, University of Arizona, Tucson, AZ. · Department of Medicine, Dana Farber Cancer Institute, Boston, MA. · Department of Medicine, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 25450035
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Barts Cancer Institute, Queen Mary University of London, Barts Experimental Cancer Medicine Centre, London EC1M 6BQ, UK. · Yale Cancer Center, 333 Cedar Street, WWW211, New Haven, Connecticut 06520, USA. · Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, USA. · Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Gustave Roussy, 114 Rue Édouard Vaillant, 94805 Villejuif, France. · Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital. Passeig Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · Sarah Cannon Research Institute, 3322 West End Avenue, Suite 900, Nashville, Tennessee 37203, USA. · University of Nevada School of Medicine and US Oncology/Comprehensive Cancer Centers of Nevada, 3730 S. Eastern Avenue, Las Vegas, Nevada 89169, USA. · Pubmed 25428503
  • Division of Urology and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24568895
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Department of Urology, Stanford University Medical Center, Stanford, CA, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 24491306
  • Fox Chase Cancer Center, Philadelphia, PA · Thomas Jefferson University Hospital, Philadelphia, PA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Fox Chase Cancer Center, Philadelphia, PA. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25385730
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
2015
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 24674655
2014
  • Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Christopher Tretter, Lahey Clinic, Burlington; Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA; Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA; and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme Steele, Michelle Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, and Jonathan E. Rosenberg, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Christopher Tretter, Lahey Clinic, Burlington; Glenn J. Bubley, Beth Israel Deaconess Medical Center, Boston, MA; Leonard J. Appleman, University of Pittsburgh, Pittsburgh, PA; and Jonathan E. Rosenberg, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24821883
  • Dana-Farber Cancer Institute, Boston, Massachusetts; University of Rochester, Rochester, New York. · Pubmed 24846059
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2012
  • Department of Imaging, Dana-Farber Cancer Institute, MA, USA. · Pubmed 22176867
Hospital del Mar
2017
  • Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: · Universitat Pompeu Fabra, Plaça de la Mercè 10, 08002 Barcelona, Spain. Electronic address: · Cancer Research Program, PSMAR-IMIM (Hospital del Mar Medical Research Institute), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain; Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, USA. Electronic address: · Pubmed 29121502
  • Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA, 02215, USA. · IMIM-Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, 1st Floor, 08003, Barcelona, Spain. · Pubmed 28493171
  • University of Washington, Seattle, Washington. · Icahn School of Medicine at Mount Sinai, New York, New York. · University of Southampton, Southampton, England. · National and Kapodistrian University of Athens, Athens, Greece. · Dana Farber Cancer Institute, Boston, Massachusetts. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Hospital del Mar, Barcelona, Spain. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Georges François Leclerc Center, Dijon, France. · Université de Bourgogne, Dijon, France. · Barts and the London School of Medicine, London, England. · City of Hope, Duarte, California. · Heinrich-Heine-University, Düsseldorf, Germany. · University of Michigan, Ann Arbor, Michigan. · University of Utah, Salt Lake City, Utah. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Karmanos Cancer Institute, Detroit, Michigan. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28000388
2016
  • Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston MA, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 27283319
2015
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Urology, Tan Tock Seng Hospital, Singapore. Electronic address: · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25836936
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2014
  • Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. · Pubmed 25070136
  • UAB Comprehensive Cancer Center, Birmingham, AL. · University Hospital del Mar-IMIM, Barcelona, Spain. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Heinrich Heine University, Dusseldorf, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · University Federico II, Naples, Italy. · Institut de Recherche Pierre Fabre, Boulogne, France. · Fox Chase Cancer Center, Philadelphia, PA. · Princess Margaret Hospital, Toronto, ON, Canada. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · University of North Carolina, Chapel Hill, NC. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · McMaster University, Hamilton, ON, Canada. · Pubmed 25035282
  • Harvard School of Public Health, Harvard University, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Harvard School of Public Health, Harvard University, Boston, MA, USA. · Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA. · Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain. Electronic address: · Pubmed 24018020
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Wilmot Cancer Center, University of Rochester, Rochester, NY. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Hospital del Mar Research Institute-IMIM, Barcelona, Spain. · George Whipple Lab for Cancer Research, Department of Pathology and Urology, University of Rochester, Rochester, NY. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Pubmed 23911686
  • Department of Internal Medicine/Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · University Hospital del Mar-IMIM, Barcelona, Spain. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. · Department of Medicine/Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Institut de Recherche Pierre Fabre, Boulogne, France. · Department of Urology, Heinrich Heine University, Dusseldorf, Germany. · Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Department of Medicine, Princess Margaret Hospital, Toronto, ON, Canada. · Department of Medicine/Hematology and Medical Oncology, Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY. · Department of Internal Medicine/Medical Oncology, Yale University Cancer Center, New Haven, CT. · Department of Oncology, Wayne State University, Detroit, MI. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. · Department of Medicine/Hematology-Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medicine/Hematology-Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine/Hematology-Oncology, UAB Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Pubmed 24220220
2013
  • Dana-Farber and Brigham and Women's Cancer Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA and Hospital del Mar-IMIM-IMAS, Doctor Aiguader 88, 08003 Barcelona, Spain. · Pubmed 23982523
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
2011
2010
  • Department of Medical Oncology, University Hospital Del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain. · Pubmed 20231682
2008
  • Department of Medical Oncology, University Hospital del Mar, Barcelona, Spain. · Pubmed 18707804
  • Medical Oncology Service, University Hospital Del Mar, Paseo Maritimo 25-29, Barcelona, Spain. · Pubmed 18538178
2007
  • Hospital del MAR-IMAS, Autónoma University of Barcelona, Barcelona, Spain. · Pubmed 17382797
2015
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
2014
  • Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain. · Pubmed 24486590
2011
  • Medical Oncology Service, University Hospital del Mar, Barcelona, Spain. · Pubmed 21360040
Miscellaneous institutions in Barcelona
2015
  • Bladder Cancer Center, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, University Hospital de Mar-IMIM, Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Athens and Hellenic Co-operative Oncology Group, Athens, Greece. · Center for Molecular Oncologic Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · The Johns Hopkins University School of Medicine, Baltimore, Maryland. · Hospital de Mar Research Institute-IMIM, Barcelona, Spain. · Hospital Parc Tauli, Sabadell, Spain. · IIS-Fundacion Jimenez Diaz, Madrid, Spain. · Memorial Sloan Kettering Cancer Center, New York City, New York. · Pubmed 25720673
Universitat Autonoma de Barcelona
2012
  • Medical Oncology Service, Parc de Salut Mar, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 23040256
2012
  • Department of Medical Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. · Pubmed 22595043
Universitat de Barcelona
2007
  • Hospital del MAR-IMAS, Autónoma University of Barcelona, Barcelona, Spain. · Pubmed 17382797
16 Other Locations Show
Yearly article counts 08812137631023
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.